This means there can be a lot of details that you are rightfully curious about when it comes to taking up a new practice counseling clients taking Wegovy or Ozempic

Disclosures: Marie-Agns M'CALLUM: Nothing to Disclose, Quang Toan PHAM: Nothing to Disclose, Kristen Vieira-Lomasney: Nothing to Disclose, Eytan Haddad: Nothing to Disclose, Silvia Selleri: Abcellera Biologics: Employee, Massimiliano Paganelli: Morphocell Technologies: Executive role 1162 ASSOCIATION OF GLUCAGON-LIKE PEPTIDASE 1 RECEPTOR AGONIST WITH LIVER AND NON-LIVER COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE Mindie Nguyen 1 Xianhua Mao 1 Xinrong Zhang 1 Rongtao Lai 2 Ka-Shing Cheung 3 Man-Fung Yuen 3 Ramsey Cheung 1 Wai-Kay Seto 3 , 1 Stanford University Medical Center, 2 Shanghai Jiao Tong University School of Medicine, 3 The University of Hong Kong Background: Although individuals with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease (diabetic MASLD) face a higher lifelong risk of developing liver and non-liver morbidities, there so far are limited effective pharmacological strategies to reduce the disease burden in this population

Many women report that once cravings calm down and they feel full longer, their emotional eating becomes much easier to manage
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT- 4 Randomized Clinical Trial
Premenstrual Dysphoric Disorder and Hormonal Health